A serious, irreversible eye disease known as myopic maculopathy is on the rise. Yalin Wang, a professor of computer science and engineering in the School of Computing and Augmented Intelligence at ASU, is leading a team to find solutions
Tag: Opthalmology
Tracy M. Valorie joins Glaucoma Research Foundation Board of Directors
Glaucoma Research Foundation, the nation’s most experienced foundation dedicated solely to glaucoma research and education, has elected Tracy M. Valorie, BS, MBA to its Board of Directors.
Eclipse Tips to Protect Your Eyes
On April 8, a rare solar eclipse will be visible in a path across North America. While many are eager to experience the eclipse, prolonged exposure to the sun’s rays can lead to vision distortion or potential permanent damage. UC…
King Chulalongkorn Memorial Hospital Doctors Suggest Ways to Prevent Glaucoma through Early Detection
The Excellence Center for Glaucoma, Department of Ophthalmology, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, and Thai Glaucoma Society encourage all of us to realize the significance of glaucoma as it is the world’s number 1 cause of irreversible blindness. In Thailand, over 2 million people are affected by glaucoma.
ARVO Foundation Announces Recipients of 2023 Pfizer Ophthalmics Carl Camras Translational Research Award
The Association for Research in Vision and Ophthalmology (ARVO) Foundation announced today the recipients of the 2023 Pfizer Ophthalmics Carl Camras Translational Research Award:Granted annually to young investigators working in areas of translational research, each recipient will be awarded $12,000.
Winners of ARVO Foundation Collaborative Research Fellowship Announced
The Association for Research in Vision and Ophthalmology (ARVO) announced today the recipients of the 2023 ARVO Foundation Collaborative Research Fellowship: José Arthur Milhomens Filho, MD; Maria Constanza Paz, PhD; Raba Thapa, PhD.With the goal of strengthening ophthalmic research capacities worldwide, the Fellowship pairs early-career researchers from developing countries with collaborating scientists in well-established research laboratories.
ARVO Foundation Announces 2023 Recipient of Genentech Career Development Award for Underrepresented Minority Emerging Vision Scientists
The Association for Research in Vision and Ophthalmology (ARVO) Foundation congratulates Edmund Arthur, OD, PhD, the 2023 recipient of the Genentech Career Development Award for Underrepresented Minority (URM) Emerging Vision Scientists. Arthur will receive a two-year grant totaling $100,000 to support research and personnel costs for establishing an independent vision research program.
High-tech imaging reveals details about rare eye disorder
Using a new imaging technique, researchers from the National Eye Institute have determined that retinal lesions from vitelliform macular dystrophy (VMD) vary by gene mutation. Addressing these differences may be key in designing effective treatments for this and other rare diseases. NEI is part of the National Institutes of Health.
‘iTEARS’ could help diagnose diseases by isolating biomarkers in tears
In ACS Nano, researchers report a nanomembrane system that harvests and purifies tiny blobs called exosomes from tears, allowing researchers to quickly analyze them for disease biomarkers. Dubbed iTEARS, the platform could enable more efficient and less invasive diagnoses for many diseases.
National Academy of Sciences names two UCI faculty members as fellows
Irvine, Calif., May 4, 2022 – Two University of California, Irvine researchers have been elected to the National Academy of Sciences, one of the world’s most respected scientific organizations. Svetlana Jitomirskaya, Distinguished Professor of mathematics, and Krzysztof Palczewski, Distinguished Professor of ophthalmology, are among 120 U.
New Research Shows Virtual School Can Harm Children’s Vision
New research confirms that increased screen time did lead to more eye strain in children, as well as a more troubling eye condition called convergence insufficiency, which can cause difficulty reading.
Keep an eye on ocular health with the return to in-person school and work
With in-person school just around the corner and a September target date for many to return to the office, a Northwestern Medicine eye expert is urging awareness of eye health. Michelle E. Andreoli, MD, an ophthalmologist at Northwestern Medicine Regional Medical Group…
New Issue of the Journal of VitreoRetinal Diseases Now Available
The July/August 2021 issue of the Journal of VitreoRetinal Diseases (JVRD), the official peer-reviewed, scientific journal of the American Society of Retina Specialists, has been published.
Synthesized Very-Long-Chain Polyunsaturated Fatty Acids Improved Retinal Function in Mice
A University of Utah Health ophthalmologist is investigating how lipids known as VLC-PUFAs could be used to prevent eye disease thanks to a new way to synthesize them for research.
ARVO Foundation Announces 2021 Bert M. Glaser, MD Award for Innovative Retina Research Recipient
The Association for Research in Vision and Ophthalmology (ARVO) today announced Yohei Tomita, MD, PhD, has received the 2021 Bert M. Glaser, MD Award for Innovative Research in Retina, which recognizes an early-career investigator who has made a novel discovery that impacted the understanding and/or treatment of a retinal disease or condition. Tomita is recognized with this award for his retinal translational research, with a focus on diabetic retinopathy (DR) and age-related macular degeneration (AMD).
Routine eye scans may give clues to cognitive decline in diabetes
In older people with type 1 diabetes, damage to the retina may be linked to memory problems and other cognitive conditions.BOSTON – (December 31, 2020) – As they age, people with diabetes are more likely to develop Alzheimer’s disease and other cognitive disorders than are people without diabetes. Scientists at Joslin Diabetes Center now have shown that routine eye imaging can identify changes in the retina that may be associated with cognitive disorders in older people with type 1 diabetes.
Wills Eye Earns Top Hospital Ranking by Nation’s Ophthalmologists
Wills Eye Hospital has earned a top national ranking for the 31st consecutive year on U.S. News & World Report’s Annual Best Hospital’s Survey.
ARVO and ARVO Foundation Awards Nominations Opening July 1
The Association for Research in Vision and Ophthalmology (ARVO) and ARVO Foundation for Eye Research announce the opening of nominations for their respective awards, including three new awards— the Genentech Career Development Award for Underrepresented Minority Emerging Vision Scientists, the Achievements in Eye and Vision Advocacy Award, and the Emerging Advocate Award—on July 1, 2020.
AAVCOVID Vaccine Program from Mass. Eye and Ear and Mass General Enters Manufacturing Agreement with Gene Therapy Leader AveXis, a Novartis Company
AveXis, will lead the manufacturing efforts of the new AAVCOVID vaccine, utilizing its cutting-edge AAV technology for treatment of rare and life-threatening neurological genetic diseases. AveXis has the option to manufacture the AAV vaccine for additional clinical development, registration and/or commercial activities.
WILLS EYE HOSPITAL NAMES NEW CHIEF DEVELOPMENT OFFICER
Wills Eye Hospital is pleased to announce John J. Zabinski has been named Chief Development Officer.